✦ LIBER ✦

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma

✍ Scribed by M. Bower; E. S. Newlands; N. M. Bleehen; M. Brada; R. J. H. Begent; H. Calvert; I. Colquhoun; P. Lewis; M. H. Brampton

Publisher: Springer
Year: 1997
Tongue: English
Weight: 139 KB
Volume: 40
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050691

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of temozolomide in childr

Phase II trial of temozolomide in children with recurrent high-grade glioma

✍ A. Ruggiero; G. Cefalo; M.L. Garré; M. Massimino; C. Colosimo; G. Attinà; I. Laz 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 170 KB

Phase II trial of ritonavir/lopinavir in

Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas

✍ Manmeet S. Ahluwalia; Carol Patton; Glen Stevens; Tanya Tekautz; Lilyana Angelov 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 192 KB

Temozolomide for recurrent or progressiv

Temozolomide for recurrent or progressive high-grade malignant glioma: Results of an Austrian multicenter observational study

✍ Marco Hassler; Michael Micksche; Günther Stockhammer; Josef Pichler; Franz Payer 📂 Article 📅 2006 🏛 Springer Vienna 🌐 English ⚖ 174 KB

A phase II trial of vinorelbine and inte

A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases

✍ Fabio M. Iwamoto; Antonio M. Omuro; Jeffrey J. Raizer; Craig P. Nolan; Adília Ho 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 163 KB

Multi-institutional phase II study of te

Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas

✍ Casilda Balmaceda; David Peereboom; Susan Pannullo; Ying Kuen K. Cheung; Paul G. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract ## BACKGROUND. The prognosis for patients with recurrent high‐grade gliomas is poor and treatment options are limited. Current chemotherapeutic regimens can improve clinical outcomes, but extend survival by only a few months. Temozolomide is a methylating agent that is typically admini

A phase II study of O6-benzylguanine and

A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study

✍ Katherine E. Warren; Sri Gururangan; J. Russell Geyer; Roger E. McLendon; Tina Y 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 225 KB